Strategic partnerships CARRA maintains a broad network of over 440 pediatric rheumatologists and researchers across more than 110 sites, presenting a strong opportunity to co-create and fund multi-site research programs or registry expansions with partners like LADA and Arthritis Foundation.

Research monetization With the CARRA Registry being a cornerstone data asset, there is potential to offer data analytics services, translational research support, and sponsored research collaborations to pharma, biopharma, and medical device companies seeking pediatric rheumatology insights.

Leadership alignment Recent leadership changes and high-profile partnerships signal growing visibility; this creates an opening to engage senior leadership for strategic funding, joint initiatives, and long-term sponsorship opportunities in youth autoimmune disease research.

Clinical impact expansion CARRA’s mission to prevent, treat and cure pediatric rheumatic diseases, plus collaborations with organizations like LADA, points to opportunities for joint mental health and patient-reported outcomes research, expanding grant-funded projects and patient support programs.

Fundraising readiness As a 501(c)(3) charitable organization with collaborations and awards programs, CARRA is well-positioned to engage foundations and donors for targeted funding rounds, research fellowships, and scalable registry enhancements.